Tag: pharmaceutical industry news
AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
Government Changes Rules to Make Doing Business Easier for Pharma and Food Companies
In a major step toward trust-based governance, the Government of India has operationalised key reforms under the Jan VishwasAct, 2026. The initiative rationalises minor offences...
Sun Pharma Acquires Checkpoint Therapeutics in ₹2,480 Crore Global Expansion Move
Sun Pharmaceutical Industries Limited, one of the world’s leading pharmaceutical giants, announced a definitive agreement to acquire Checkpoint Therapeutics in a transaction valued at...
Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis
In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of Pharmaceuticals (DoP) has granted an in-principle...
GSK expands deal worth $ 10.6B for lung cancer treatment
GSK plc and Nuvalent, Inc. announced that they have entered into a definitive agreement under which GSK will acquire Nuvalent, a clinical-stage biopharmaceutical company focused on...
Lupin Gets U.S. FDA Approval for Ranluspec™ to Treat Retinal Disorders
Lupin Limited has secured U.S. FDA approval for Ranluspec™ (ranibizumab-hkdz), an interchangeable biosimilar to Genentech’s Lucentis® — a milestone that reshapes patient access to sight-saving biologics across...